Viewing StudyNCT04256941



Ignite Creation Date: 2024-05-06 @ 2:14 PM
Last Modification Date: 2024-10-26 @ 1:27 PM
Study NCT ID: NCT04256941
Status: COMPLETED
Last Update Posted: 2024-04-16
First Post: 2020-01-21

Brief Title: Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation the INTERACT Study
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Organization Data

Organization: MD Anderson Cancer Center
Class: OTHER
Study ID: 2018-0287
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MD Anderson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH